Page last updated: 2024-09-04

ivabradine and Diabetic Cardiomyopathies

ivabradine has been researched along with Diabetic Cardiomyopathies in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S; Gao, X; Luo, J; Qian, X; Ren, X; Ye, P; Zhang, J; Zuo, G1
Chao, YL; Chen, SL; Gao, HB; Gao, XF; Ge, Q; Ge, Z; Gu, Y; Hu, ZY; Luo, J; Ren, XM; Wang, F; Wu, W; Ye, P; Zhang, JJ; Zuo, GF1
Chen, SL; Hu, ZY; Li, B; Li, MH; Zuo, GF1

Other Studies

3 other study(ies) available for ivabradine and Diabetic Cardiomyopathies

ArticleYear
Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy.
    Journal of cellular physiology, 2019, Volume: 234, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Cytokines; Diabetic Cardiomyopathies; Inflammation Mediators; Ivabradine; JNK Mitogen-Activated Protein Kinases; Male; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Rats; Recovery of Function; Signal Transduction; Streptozocin

2019
Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy.
    Journal of molecular and cellular cardiology, 2019, Volume: 130

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Enzyme Activation; Ivabradine; Male; Mice; Molecular Docking Simulation; Myocytes, Cardiac; NF-kappa B; Protein Phosphatase 2; Rats; Signal Transduction

2019
I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice.
    BMC cardiovascular disorders, 2014, Oct-31, Volume: 14

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzazepines; Cardiotonic Agents; Caspase 3; Cells, Cultured; Diabetes Mellitus; Diabetic Cardiomyopathies; Disease Models, Animal; Down-Regulation; Ivabradine; Male; Matrix Metalloproteinase 2; Mice; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Recovery of Function; Signal Transduction; Ventricular Function, Left

2014